NCT01083615 2016-10-12A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)Achieve Life SciencesPhase 3 Terminated14 enrolled
NCT01497470 2016-10-10A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment RegimenAchieve Life SciencesPhase 1 Completed36 enrolled
NCT01630733 2016-07-01A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerAchieve Life SciencesPhase 3 Unknown700 enrolled
NCT00327340 2012-10-05Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPCAchieve Life SciencesPhase 2 Completed70 enrolled 11 charts
NCT00138658 2012-02-06A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)Achieve Life SciencesPhase 1/2 Completed85 enrolled 16 charts